Severe Coagulopathy following Intraoperative Use of Topical Thrombin
暂无分享，去创建一个
[1] W. Flinn,et al. Coagulopathy as a result of factor V inhibitor after exposure to bovine topical thrombin. , 2002, Journal of vascular surgery.
[2] W. Muntean,et al. Inhibitor to factor V after exposure to fibrin sealant during cardiac surgery in a two‐year‐old child , 1994, Acta paediatrica.
[3] S. Rapaport,et al. Clinical significance of antibodies to bovine and human thrombin and factor V after surgical use of bovine thrombin. , 1992, American journal of clinical pathology.
[4] J. Zehnder,et al. Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin. , 1990, Blood.
[5] M. Wener,et al. Iatrogenic immunization with bovine thrombin: a mechanism for prolonged thrombin times after surgery. , 1989, Annals of internal medicine.
[6] T. L. Cole,et al. Isolation and study of an acquired inhibitor of human coagulation factor V. , 1986, The Journal of clinical investigation.
[7] R. Desser,et al. Successful management of bleeding in a patient with factor V inhibitor by platelet transfusions. , 1980, Blood.